Annual D&A
$1.39 M
-$37.00 K-2.59%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual depreciation & amortization is $1.39 million, with the most recent change of -$37.00 thousand (-2.59%) on December 31, 2023.
- During the last 3 years, ZNTL annual D&A has risen by +$1.23 million (+768.12%).
- ZNTL annual D&A is now -2.59% below its all-time high of $1.43 million, reached on December 31, 2022.
Performance
ZNTL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$321.00 K
-$6000.00-1.83%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly depreciation & amortization is $321.00 thousand, with the most recent change of -$6000.00 (-1.83%) on September 30, 2024.
- Over the past year, ZNTL quarterly D&A has dropped by -$27.00 thousand (-7.76%).
- ZNTL quarterly D&A is now -14.40% below its all-time high of $375.00 thousand, reached on September 30, 2022.
Performance
ZNTL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.31 M
-$27.00 K-2.02%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM depreciation & amortization is $1.31 million, with the most recent change of -$27.00 thousand (-2.02%) on September 30, 2024.
- Over the past year, ZNTL TTM D&A has dropped by -$102.00 thousand (-7.23%).
- ZNTL TTM D&A is now -9.22% below its all-time high of $1.44 million, reached on March 31, 2023.
Performance
ZNTL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ZNTL Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.6% | -7.8% | -7.2% |
3 y3 years | +768.1% | -7.8% | -7.2% |
5 y5 years | +2623.5% | -7.8% | -7.2% |
ZNTL Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -2.6% | +155.3% | -14.4% | +53.6% | -9.2% | +140.6% |
5 y | 5-year | -2.6% | +1151.3% | -14.4% | +872.7% | -9.2% | +1079.3% |
alltime | all time | -2.6% | +2623.5% | -14.4% | +1428.6% | -9.2% | +6133.3% |
Zentalis Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $321.00 K(-1.8%) | $1.31 M(-2.0%) |
Jun 2024 | - | $327.00 K(+0.9%) | $1.34 M(-1.3%) |
Mar 2024 | - | $324.00 K(-3.9%) | $1.35 M(-2.6%) |
Dec 2023 | $1.39 M(-2.6%) | $337.00 K(-3.2%) | $1.39 M(-1.6%) |
Sep 2023 | - | $348.00 K(+1.2%) | $1.41 M(-1.9%) |
Jun 2023 | - | $344.00 K(-4.4%) | $1.44 M(-0.3%) |
Mar 2023 | - | $360.00 K(+0.3%) | $1.44 M(+1.1%) |
Dec 2022 | $1.43 M(+162.1%) | $359.00 K(-4.3%) | $1.43 M(+11.8%) |
Sep 2022 | - | $375.00 K(+7.8%) | $1.28 M(+22.9%) |
Jun 2022 | - | $348.00 K(+1.2%) | $1.04 M(+28.3%) |
Mar 2022 | - | $344.00 K(+64.6%) | $809.00 K(+48.7%) |
Dec 2021 | $544.00 K | $209.00 K(+52.6%) | $544.00 K(+47.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $137.00 K(+15.1%) | $368.00 K(+30.5%) |
Jun 2021 | - | $119.00 K(+50.6%) | $282.00 K(+40.3%) |
Mar 2021 | - | $79.00 K(+139.4%) | $201.00 K(+25.6%) |
Dec 2020 | $160.00 K(+44.1%) | $33.00 K(-35.3%) | $160.00 K(-4.8%) |
Sep 2020 | - | $51.00 K(+34.2%) | $168.00 K(+18.3%) |
Jun 2020 | - | $38.00 K(0.0%) | $142.00 K(+10.9%) |
Mar 2020 | - | $38.00 K(-7.3%) | $128.00 K(+15.3%) |
Dec 2019 | $111.00 K(+117.6%) | $41.00 K(+64.0%) | $111.00 K(+58.6%) |
Sep 2019 | - | $25.00 K(+4.2%) | $70.00 K(+55.6%) |
Jun 2019 | - | $24.00 K(+14.3%) | $45.00 K(+114.3%) |
Mar 2019 | - | $21.00 K | $21.00 K |
Dec 2018 | $51.00 K | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual D&A year-on-year change?
- What is Zentalis Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly D&A year-on-year change?
- What is Zentalis Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM D&A year-on-year change?
What is Zentalis Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ZNTL is $1.39 M
What is the all time high annual D&A for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual depreciation & amortization is $1.43 M
What is Zentalis Pharmaceuticals annual D&A year-on-year change?
Over the past year, ZNTL annual depreciation & amortization has changed by -$37.00 K (-2.59%)
What is Zentalis Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ZNTL is $321.00 K
What is the all time high quarterly D&A for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly depreciation & amortization is $375.00 K
What is Zentalis Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ZNTL quarterly depreciation & amortization has changed by -$27.00 K (-7.76%)
What is Zentalis Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ZNTL is $1.31 M
What is the all time high TTM D&A for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM depreciation & amortization is $1.44 M
What is Zentalis Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ZNTL TTM depreciation & amortization has changed by -$102.00 K (-7.23%)